symbol,statement_type,period_end,line_item,value
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,-1821799000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Issuance Of Debt,503935000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Issuance Of Capital Stock,1907304000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-2142366000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,End Cash Position,273812000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,169451000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,104361000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,2998860000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Net Other Financing Charges,414025000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-83429000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,1907304000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Common Stock Issuance,1907304000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,503935000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,279994000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Short Term Debt Issuance,279994000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,223941000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Issuance,223941000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-3215066000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,-236407000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,-836799000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,-836799000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Net Intangibles Purchase And Sale,-902035000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Purchase Of Intangibles,-902035000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-1239825000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,506000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-1240331000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,320567000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-371520000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,-1236937000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Liabilities,583911000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Change In Payable,
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,-513708000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,-1307140000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,83429000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,289817000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Amortization Cash Flow,
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Depreciation,289817000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Pension And Employee Benefit Expense,2505000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,612000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,1517000.0
MOREPENLAB.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,1551094000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,-79609000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Issuance Of Debt,38351000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Issuance Of Capital Stock,0.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-813355000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,End Cash Position,169451000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,216658000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,-47207000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,52049000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Net Other Financing Charges,50800000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-37102000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,0.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Common Stock Issuance,0.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,38351000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,14046000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Short Term Debt Issuance,14046000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,24305000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Issuance,24305000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-833002000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,-7169000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,-13010000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,-13010000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Net Intangibles Purchase And Sale,-99547000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Purchase Of Intangibles,-99547000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-713276000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,532000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-713808000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,733746000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-381153000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,-581232000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Liabilities,794768000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Change In Payable,
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,-197079000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,-1178921000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,37102000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,334695000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Amortization Cash Flow,157810000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Depreciation,334695000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Pension And Employee Benefit Expense,-27524000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,2305000.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,0.0
MOREPENLAB.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,1354157000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,-1371426000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Issuance Of Debt,
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Issuance Of Capital Stock,1371520000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-459720000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,End Cash Position,216658000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,158026000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,58632000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,1435431000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Net Other Financing Charges,17768000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-19808000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Net Common Stock Issuance,1371520000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Common Stock Issuance,1371520000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,65951000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Net Short Term Debt Issuance,69827000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Short Term Debt Issuance,
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,-3876000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Issuance,
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-465093000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Net Other Investing Changes,-5373000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,0.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Net Intangibles Purchase And Sale,-103514000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Purchase Of Intangibles,-103514000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-356206000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,0.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-356206000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,-911706000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-165539000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,-1582767000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Liabilities,-1422764000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Change In Payable,
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,469678000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,-629681000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,19808000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,279304000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Amortization Cash Flow,155296000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Depreciation,124008000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Pension And Employee Benefit Expense,-20062000.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,0.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,0.0
MOREPENLAB.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,557553000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,-1276082000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Issuance Of Debt,
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Issuance Of Capital Stock,525000000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-673680000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,End Cash Position,158026000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,413869000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,-255843000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,663344000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Net Other Financing Charges,123111000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Net Common Stock Issuance,525000000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Common Stock Issuance,525000000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,15233000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Net Short Term Debt Issuance,10305000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Short Term Debt Issuance,
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,4928000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Issuance,
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-316785000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Net Other Investing Changes,339813000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,15411000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Net Intangibles Purchase And Sale,-219218000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Purchase Of Intangibles,-219218000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-452791000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,1671000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-454462000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,-602402000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-249323000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,-1814687000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Liabilities,516260000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Change In Payable,24826000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,-1005287000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,-1325660000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,-73655000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,276425000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Amortization Cash Flow,
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Depreciation,276425000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Pension And Employee Benefit Expense,-4600000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,-3602000.0
MOREPENLAB.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,1267026000.0
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Issuance Of Debt,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Issuance Of Capital Stock,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Net Other Financing Charges,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,-17882000.0
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Net Common Stock Issuance,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Common Stock Issuance,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Net Short Term Debt Issuance,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Short Term Debt Issuance,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Issuance,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Net Other Investing Changes,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Net Intangibles Purchase And Sale,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Purchase Of Intangibles,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Liabilities,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Amortization Cash Flow,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Depreciation,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Pension And Employee Benefit Expense,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,
MOREPENLAB.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
